| Literature DB >> 32801628 |
Mantapond Ittarat1,2, Thanapong Somkijrungroj2,3, Sunee Chansangpetch2,4, Pear Pongsachareonnont2,3.
Abstract
PURPOSE: To summarize current surgical techniques for treating primary macular holes (MHs).Entities:
Keywords: internal limiting membrane peeling; macular hole; macular hole surgery; stem cell therapy
Year: 2020 PMID: 32801628 PMCID: PMC7398756 DOI: 10.2147/OPTH.S262877
Source DB: PubMed Journal: Clin Ophthalmol ISSN: 1177-5467
Classification in Idiopathic Macular Holes
| Stage in Common Use for Full-Thickness MH | Gass-Based Classification | IVTS Classification |
|---|---|---|
| 0 | Previous MH with no foveal architecture changes and VMA in the fellow eye | VMA |
| 1 | Impending macular hole with foveal architecture change | VMT without MH |
| 2 | MH with preexisting VMA | Small-sized or medium-sized MH with VMT |
| 3 | ≥ 400 µm MH without VMA | Medium-sized or Large-sized MH with VMT |
| 4 | MH with complete vitreous separation | Any sized MH without VMT |
Abbreviations: IVTS, International Vitreomacular Traction Study; VMA, vitreomacular attachment; MH, idiopathic full-thickness macular hole; VMT, vitreomacular traction; RPE, retinal pigment epithelium.
Figure 1Multi-layers of ILM in macular hole during vitrectomy surgery with modified ILM flap technique.
Reported Techniques and Outcomes in Large Macular Holes
| Study (Year) | Surgical Technique | Number (Eyes) | MH Size (µm) | Hole Closure Rate (%) | VA (Pre-Operative, Postoperative) Improvement | Mean Follow-Up Time (Months) |
|---|---|---|---|---|---|---|
| Al Sabti et al (2009) | Extended ILM peeling | 2 | Range: 773–1147 | 100 | (CF, 20/300), (20/400, 20/50) | 10.5 |
| Michalewska et al (2010) | Inverted ILM flap | 50 | Range: 415–1618 | 98 | 0.078, 0.28a | 12 |
| Kumar et al (2013) | Tapping the edges of MH | 28 | Mean MHI 0.32 | 89 | 0.86, 0.43b | 6 |
| Charles et al (2013) | Arcuate retinotomy temporal to macular | 6 | Mean 658 | 83 | 50% of cases improvement in VA | 26.5 |
| Michalewska et al (2015) | Temporal inverted ILM flap | 44 | Range: 400–841 | 93 | 1.03, 0.45b | 12 |
| Andrew et al (2016) | Folded inverted ILM flap | 24 | Mean 528 | 100 | Mean 20/160, 20/60 | 12 |
| Chakrabarti et al (2017) | Macular plug without gas tamponade | 26 | Mean 893 | 100 | 1.0, 0.50c | 12 |
| Ch’ng et al (2018) | ILM peel with gas tamponade | 258 | Range: 400–1416 | 90 | 0.95, 0.62b | 3 |
| Rizzo et al (2018) | ILM peeling | 300 | MH ≥ 400 | 79 | 0.79, 0.56b | 9 |
| ILM flap | 320 | 96 | 0.81, 0.49b | |||
| Zhang et al (2018) | Vitrectomy, ILM peeling, MSCs or MSC-Exos intravitreal injection | 7 Large and refractory MHs | Range: 695–932 | 86 | VA improved | 6 |
| Ghassemi F et al (2019) | Inverted ILM flap technique | 72 | Mean 553–548 | 87–100 | 0.90–0.92b, 0.53–0.55b | 6 |
Notes: aMean decimal Snellen; bmean logarithm of the minimum angle of resolution units; cmedian logarithm of the minimum angle of resolution units
Abbreviations: MH, idiopathic full-thickness macular hole; ILM, internal limiting membrane; VA, visual acuity; MHI, macular hole index; CF, counting finger; MSC, mesenchymal stem cells; MSC-Exos, MSC-derived exosome.
Reported Techniques and Outcomes in Persistent/Recurrent Macular Holes
| Study (Year) | Surgical Technique | Number (Eyes) | Hole Closure Rate (%) | VA (Pre-Operative, Postoperative) Improvement | Mean Follow-Up Time (Months) |
|---|---|---|---|---|---|
| Ezra et al (1997) | Membranectomy and autologous serum | 46 persistent MHs | 80 | Median: 20/120, 20/60 | 10 |
| D’souza et al (2011) | Repeated PPV and ILM re-peeling | 21 persistent MHs | 52 | 0.044, 0.065a | 12 |
| Rizzo et al (2009) | Repeated PPV and injected Densiron-68 | 23 persistent MHs | 87 | 82% of cases improvement in VA at least 3 lines | 12 |
| Reis et al (2012) | Radial retinal incisions | 7 persistent MHs | 100 | ≤0.05, 0.24a | 12 |
| Che et al (2014) | Repeated PPV and enlarge ILM peeling | 13 persistent MHs | 62 | 1.03,0.92b | 13 |
| Morizane et al (2014) | Autologous transplantation of ILM +viscoelastic | 10 refractory MHs | 90 | 0.99, 0.57b | 12 |
| Chen et al (2016) | Lens capsule flap transplantation | 20 persistent MHs (10AC, 10 PC) | 100 (AC) | 1.53, 1.07b | 4 |
| Grewal et al (2016) | Autologous neurosensory retinal free flap | 1 refractory myopic MH | 100 | 20/200, 20/80 | 3 |
| Szigiato et al (2016) | Induction of macular detachment | 8 persistent MHs | 90 | 1.49, 1.17b | 6 |
| Pires et al (2017) | ILM translocation | 12 persistent MHs | 91 | Mean: 20/400, 20/160 | 12 |
| Felfeli et al (2018) | Macular hole hydrodissection | 39 persistent, chronic and/or large MHs | 87 | 95% of cases improvement in VA | 10.7 |
| Caporossi et al (2019) | Human amniotic membrane plug | 16 recurrent high myopic MH | 94% after one surgical intervention | 1.00, 0.67b | 12 |
Notes: aMean decimal Snellen; bmean logarithm of the minimum angle of resolution units.
Abbreviations: MH, idiopathic full-thickness macular hole; ILM, internal limiting membrane; PPV, pars plana vitrectomy; VA, visual acuity; AC, anterior capsule; PC, posterior capsule; MSC, mesenchymal stem cell; MSC-Exos, mesenchymal stem cells-derived exosomes.
Figure 2A schematic diagram of resuming choice of surgical methods for idiopathic macular hole: perspective.
Abbreviations: MH, idiopathic macular hole; DD, disc diameter; VA, visual acuity; ILM, internal limiting membrance; ERM, epiretinal membrane; PPV, pars plana vitrectomy; hAM, human amniotic membrane; MSCs, mesenchymal stem cells; MSC-Exos, MSC-derived exosomes; *, limited evidence